Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Casesgenetics-dysmorphology-and-metabolism

Paeds Cases · genetics-dysmorphology-and-metabolism

Usher syndrome — clinical case

A clinical case of Usher syndrome type I: a five-year-old girl with congenital profound sensorineural hearing loss managed with cochlear implantation who now presents with night blindness and progressive visual field constriction, illustrating the two-wave presentation, the electroretinographic and molecular confirmation, and the multidisciplinary management of dual sensory loss.

long-case
On this page & tools

Target exams

RACP DCEMRCPCH ClinicalABP General Pediatrics

Target exams

RACP DCEMRCPCH ClinicalABP General Pediatrics
Prompt
A five-year-old girl with congenital profound sensorineural hearing loss identified by newborn hearing screening, cochlear implanted at ten months, and doing well in a bilingual sign-and-spoken-language programme, is brought by her parents who have noticed over the past six months that she is increasingly reluctant to go outside after dusk, bumps into furniture in dim rooms, and has started holding the wall when descending stairs. Her classroom teacher reports she is struggling with spatial awareness during physical activity.

This long case tests the candidate's ability to integrate the cochlear implant history with the new visual symptoms, recognise Usher syndrome as the single most common cause of dual deaf-blindness, and construct a management plan that addresses the retinal degeneration, the educational and mobility implications, and the genetic counselling of the whole family. The key teaching points are the two-wave presentation, the role of electroretinography in confirming subclinical retinal disease years before symptomatic visual field loss, and the rationale for baseline ophthalmology in every deaf child of unknown cause. [4]

The case unfolds in three phases. The first phase establishes the history of the congenital hearing loss and the cochlear implant outcome, confirming that the aetiology was never molecularly resolved. The second phase focuses on the night blindness and visual field constriction, the ophthalmology and electroretinographic findings of retinitis pigmentosa, and the molecular confirmation of an Usher gene variant. The third phase addresses the multidisciplinary management: low-vision support, mobility and orientation training, educational planning for progressive visual impairment, genetic counselling for the autosomal-recessive recurrence risk, and cascade testing of the younger sibling who currently has normal hearing. [2] [4]

References

  1. [1]Morton CC, Nance WE. Newborn hearing screening--a silent revolution. N Engl J Med, 2006.PMID 16707752
  2. [2]Lieu JEC, Kenna M, Anne S, Davidson L. Hearing Loss in Children: A Review. JAMA, 2020.PMID 33258894
  3. [4]Castiglione A, Moller C. Usher Syndrome. Audiol Res, 2022.PMID 35076463
  4. [10]De Silva SR, Arno G, Robson AG, et al. The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies. Prog Retin Eye Res, 2021.PMID 32860923